Protocol Amendment
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
A formal written description of a change to, or clarification of, an approved clinical trial protocol, distributed to and, where substantial, approved by regulators and ethics committees before implementation. Amendments may be substantial, affecting safety, scientific validity, or subject rights, or administrative, and each requires version control across all trial documents.
Amendments are commonly triggered by new safety data, feasibility problems at sites, a DMC recommendation, or a recurring pattern of protocol deviations that reveals a design flaw rather than isolated site error.
Classifying an amendment as substantial or non-substantial/administrative determines the approval pathway: substantial changes generally require prior regulatory and ethics committee approval before implementation, while administrative changes may only need notification.
A change must be propagated consistently everywhere it is relevant — the informed consent form, the CRF design, and Investigator’s Brochure cross-references — inconsistency between the amended protocol and these downstream documents is a recognized inspection finding.
- —Classified as substantial or non-substantial/administrative, which determines whether prior approval is required before implementation.
- —Substantial amendments commonly follow new safety findings, a DMC recommendation, or a recurring pattern of protocol deviations.
- —Must be propagated consistently to the informed consent form, CRF design, and IB cross-references where affected.
- —Frequent or poorly justified amendments are a recognized inspection focus, as they can signal weak protocol development.
ICH E6(R3) GCP; 21 CFR 312.30 (Protocol Amendments); EU Regulation 536/2014 (CTR)
Frequently asked questions
What is Protocol Amendment?
A formal written description of a change to, or clarification of, an approved clinical trial protocol, distributed to and, where substantial, approved by regulators and ethics committees before implementation. Amendments may be substantial, affecting safety, scientific validity, or subject rights, or administrative, and each requires version control across all trial documents.
Which regulations cover Protocol Amendment?
ICH E6(R3) GCP; 21 CFR 312.30 (Protocol Amendments); EU Regulation 536/2014 (CTR)